Literature DB >> 1507201

Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship.

H el Amouri1, A Vessières, D Vichard, S Top, M Gruselle, G Jaouen.   

Abstract

Two series of novel estradiol derivatives, including cationic species, labeled with organometallic fragments Cr(CO)3, Cp*Ru+, or Cp*Rh2+ [Cp* = eta 5-C5(CH3)5] either in the 17 alpha-position or on the A-ring were synthesized, and their relative binding affinities (RBA) for the estradiol receptor were determined. The Ru(II) and the Rh(III) cationic derivatives were obtained as stable salts with the following counter anions (BF4-, PF6-, CF3SO3-). The satisfactory RBA values obtained for most complexes belonging to the 17 alpha series confirm that this position tolerates the presence of bulky neutral species. For instance, complex 4, in which the organometallic fragment Cr(CO)3 was attached to the phenyl ring of the 17 alpha-phenylethynyl fragment, exhibited an RBA value of 24%, very similar to that of the uncomplexed estrogen derivative 3. Surprisingly, the analogous cationic species 6 had no affinity for the estradiol receptor. This unprecedented result shows that the hormone binding site of the estrogen receptor does not tolerate the presence of a positive charge in the 17 alpha-position of the steroid. On the other hand, the alpha-face of the A-ring of estradiol did tolerate positively charged organometallic fragments bearing bulky substituents although the RBA value tended to decrease with increasing charge. The counterion in these cationic derivatives also affected binding affinity. For instance, the Ru(II) species 7a containing an CF3SO3- ion exhibited a reasonable RBA value (5.8%) compared to analogous species 13 with a PF6- ion (RBA of only 0.1%). Moreover, the triflate counteranion preserved the phenolic form of the A-ring of the estrogen derivative whereas the PF6- derivative was unstable and rapidly converted into the dienonylic form in buffer. The compared RBAs of the neutral and cationic species illustrate the preferences of the receptor hormone binding site in accepting or rejecting species of hydrophobic or hydrophilic character.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1507201     DOI: 10.1021/jm00095a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents.

Authors:  Zhongliang Wan; Musiliyu A Musa; Patrick Joseph; John S Cooperwood
Journal:  Mini Rev Med Chem       Date:  2013-07       Impact factor: 3.862

2.  Reactivity of (1-methoxycarbonylpentadienyl)iron(1+) cations with hydride, methyl, and nitrogen nucleophiles.

Authors:  Yuzhi Ma; Young K Yun; Julie Wondergem Nee Lukesh; Anobick Sar; Jayapal Reddy Gone; Sergey Lindeman; William A Donaldson
Journal:  Tetrahedron       Date:  2017-06-15       Impact factor: 2.457

3.  Synthesis and Pharmacological Evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents.

Authors:  Madhavi Gangapuram; Suresh Eyunni; Kinfe K Redda
Journal:  J Cancer Sci Ther       Date:  2014-04-25

4.  Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines.

Authors:  Musiliyu A Musa; M Omar F Khan; John S Cooperwood
Journal:  Lett Drug Des Discov       Date:  2009-03       Impact factor: 1.150

5.  Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators.

Authors:  Min-Jun Li; Harry M Greenblatt; Orly Dym; Shira Albeck; Adi Pais; Chidambaram Gunanathan; David Milstein; Hadassa Degani; Joel L Sussman
Journal:  J Med Chem       Date:  2011-04-19       Impact factor: 7.446

6.  Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities.

Authors:  Andrew L LaFrate; Kathryn E Carlson; John A Katzenellenbogen
Journal:  Bioorg Med Chem       Date:  2009-04-12       Impact factor: 3.641

7.  Metallocenes as Target Specific Drugs for Cancer Treatment.

Authors:  Enrique Meléndez
Journal:  Inorganica Chim Acta       Date:  2012-06-21       Impact factor: 2.545

Review 8.  Estrogen Receptor Ligands: A Review (2013-2015).

Authors:  Shabnam Farzaneh; Afshin Zarghi
Journal:  Sci Pharm       Date:  2016-04-13

9.  Synthesis and Biological Evaluations of Ring Substituted Tetrahydroisoquinolines (THIQs) as Anti-Breast Cancer Agents.

Authors:  Suresh Vk Eyunni; Madhavi Gangapuram; Bereket Mochona; Nelly Mateeva; Kinfe K Redda
Journal:  J Cancer Sci Ther       Date:  2017-07-13

10.  Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.

Authors:  Adi Pais; Hadassa Degani
Journal:  Front Oncol       Date:  2016-04-27       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.